Common strategies recommended for the management of BD depend on the involvement of the specific organ; BD is managed by molecules such as colchicine, glucocorticoids, apremilast, interferon (IFN)-α, tumor necrosis factor (TNF)-α inhibitors, and certain immunosuppressive agents, including azathioprine, thalidomide, cyclosporine-A and cyclophosphamide (7). Here, TNF is linked to Behcet disease.